Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 808, pseudogene (RN7SL808P) is a _pseudogene_ that resembles the 7SL RNA gene but is not known to produce a functional RNA or protein. The canonical 7SL RNA is the RNA component of the signal recognition particle (SRP), which is involved in directing secretory and membrane proteins to the endoplasmic reticulum in eukaryotic cells[3][5][7]. **However, RN7SL808P itself is annotated as a pseudogene** with no evidence of functional protein or established biological activity[1][6]. Pseudogenes may sometimes regulate related gene expression or influence disease processes via competing endogenous RNA mechanisms or regulatory lncRNAs, but no direct evidence is available for a specific role of RN7SL808P. **It is not a receptor, enzyme, or conventional therapeutic target**. **Key Notes:** - RN7SL808P is **not a receptor or an actionable molecular target**; it is a non-coding, processed pseudogene[1][6]. - The **canonical (functional) 7SL RNA (RN7SL1)** is important in protein targeting via the SRP pathway[3][5][7], but this is not relevant for the pseudogene copy RN7SL808P. - Some pseudogenes have regulatory functions (e.g., via miRNA sponging or antisense interactions), but these are rarely characterized and there is no information confirming such a role for RN7SL808P[4]. - **No drugs or biomarkers are associated** with RN7SL808P, and it has no therapeutic relevance at this time. **Summary judgment:** - This entry is **not a therapeutic target**. - There is **nothing inherently “incorrect” in the name** (not misspelled), but the “target” is **not functionally relevant** in the context of pharmacology or typical biological targeting, so **is_incorrect: true** (not actionable as a "target").
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 808, pseudogene (RN7SL808P).